Viewing Study NCT02145468


Ignite Creation Date: 2025-12-24 @ 5:58 PM
Ignite Modification Date: 2026-02-13 @ 8:57 AM
Study NCT ID: NCT02145468
Status: COMPLETED
Last Update Posted: 2017-06-02
First Post: 2014-05-15
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Phase 3 Clinical Outcomes Study to Compare the Incidence of Major Adverse Cardiovascular Events in Subjects Presenting With Acute Coronary Syndrome Treated With Losmapimod Compared to Placebo (LATITUDE-TIMI 60)
Sponsor: GlaxoSmithKline
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Coronary Syndrome View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Myocardial infarction View
None Acute coronary syndrome View
None Cardiovascular disease View
None p38 mitogen-activated protein kinase (MAPK) inhibitor View
None NSTEMI View
None Losmapimod View
None STEMI View